
Value of top 10 yet to close pharmaceutical deals Q1 2017
This statistic displays the top 10 yet to close pharmaceutical deals worldwide based on value announced in the first quarter of 2017. Johnson & Johnson has bid a deal for Actelion valued at 30 billion U.S. dollars.